Nicotinic antagonists

From WikiMD's Wellness Encyclopedia

Nicotinic antagonists are a class of drugs that block the action of acetylcholine (ACh) at nicotinic acetylcholine receptors (nAChRs) on neurons and muscle cells. These antagonists are crucial in the study of the nervous system and have therapeutic applications in various neurological disorders. Nicotinic receptors, named for their stimulation by nicotine, are ionotropic receptors that, when activated by their ligand acetylcholine, lead to the opening of ion channels and subsequent cellular depolarization.

Mechanism of Action[edit | edit source]

Nicotinic antagonists work by binding to nicotinic acetylcholine receptors without activating them, effectively blocking acetylcholine from binding to these sites. This inhibition prevents the ion channel from opening, which in turn inhibits depolarization. Depending on their site of action, nicotinic antagonists can be classified into two main types: neuromuscular blockers and ganglionic blockers.

Neuromuscular Blockers[edit | edit source]

Neuromuscular blocking drugs act at the neuromuscular junction and are used primarily in anesthesia to facilitate endotracheal intubation and provide muscle relaxation during surgery. They can be further divided into non-depolarizing and depolarizing blockers, based on their mechanism of action.

Ganglionic Blockers[edit | edit source]

Ganglionic blockers act on the autonomic ganglia, affecting both the sympathetic and parasympathetic nervous systems. These were once used in the treatment of hypertension but have largely been replaced by more selective drugs due to their wide range of side effects.

Clinical Uses[edit | edit source]

Nicotinic antagonists have various clinical applications, including:

  • As anesthetic aids in surgery (neuromuscular blockers)
  • Treatment of Myasthenia Gravis, a neuromuscular disease
  • Management of drug addiction in cases where nicotine is the substance of abuse

Side Effects[edit | edit source]

The use of nicotinic antagonists can lead to several side effects, such as:

  • Muscle weakness and paralysis (with neuromuscular blockers)
  • Hypotension and bradycardia (with ganglionic blockers)
  • Dry mouth, blurred vision, and urinary retention (due to parasympathetic blockade)

Examples of Nicotinic Antagonists[edit | edit source]

Some examples of nicotinic antagonists include:

  • Tubocurarine: A non-depolarizing neuromuscular blocker derived from curare.
  • Hexamethonium: A ganglionic blocker used historically to treat hypertension.
  • Mecamylamine: A ganglionic blocker that has also been used in smoking cessation therapies.

See Also[edit | edit source]


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD